Caliper Life Sciences Launches Comprehensive Drug Discovery and Development Services Business
Caliper Life Sciences, Inc. unveiled Caliper Discovery Alliances & services (CDAS), the newly-formed services organization created from the integration of NovaScreen Biosciences, a provider of in vitro discovery services, and Xenogen Biosciences, a provider of in vivo discovery services. NovaScreen was acquired by Caliper in October, 2005 and Xenogen was acquired by Caliper in August, 2006.
According to the company, through these key acquisitions, Caliper has assembled a wide range of in vitro and in vivo products and services that enable pharmaceutical companies to reduce costs while increasing the pace and clinical relevance of drug research. Caliper's strategy is to provide its customers with the tools for building an "In Vitro-In Vivo Bridge" [I-I Bridge] to address the growing pressure on the pharmaceutical industry to find new, effective drugs while minimizing the risk of adverse effects of those drugs.
Immunology research is one therapeutic area where CDAS offers assays that span the I-I Bridge. For example, a client's compound can be tested in vitro, using cell-based assays, for the compound's ability to stimulate the production of key proteins that signal an immune response. The same cell-based models have been incorporated into mice, so that in vivo compound profiling, phenotyping, or biophotonic imaging studies can be performed. By using the same cell model both in vitro and in vivo, scientists can better correlate the sets of results.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Last viewed contents
Prof Ian Frazer Appointed to Scientific Advisory Board of Avantogen's Hawaii Biotech, Inc.
Before retinal cells die, they regenerate, Penn vet blindness study finds
UF medicinal chemists modify sea bacteria byproduct for use as potential cancer drug
PharmaNeuroBoost’s lead product in major depression receives IND approval from FDA
WITec opens new regional headquarters in Singapore
A 'bio-refinery': using the chemistry of willow trees to treat municipal wastewater - Millions of litres of primary municipal wastewater can be treated sustainably using fast-growing willow trees while also producing renewable bioenergy and ‘green’ chemicals
Lymphoma overrides a key protein's quadruple locks
TxCell presents final positive results of the phase I/II clinical trial with antigen-specific Treg cells in Crohn’s disease
Two known chemotherapy agents effectively target breast cancer stem cells
Psilocybin eases existential anxiety in people with life-threatening cancer
Anti-cancer drug brewed from reprogrammed yeast - Engineered yeast cells can synthetically produce the essential cancer medicine vinblastine, an international team of scientists proved
